查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529719

發炎性腸道疾病疾病治療的市場規模、佔有率和趨勢分析報告：按類型、藥物類別、給藥途徑、通路、地區、細分市場預測，2024-2030年

Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report By Type (Crohn's Disease, Ulcerative Colitis), By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

發炎性腸道疾病疾病治療市場的成長與趨勢：

根據Grand View Research, Inc.最新報告，預計2030年全球發炎性腸道疾病治療市場規模將達277.3億美元，2024年至2030年複合年成長率為3.8%。

預計該疾病盛行率的增加、人們對發炎性腸道疾病疾病認知的激增以及有利的監管環境將在預測期內推動發炎性腸道疾病治療市場的發展。例如，2022年12月，輝瑞宣布美國FDA已接受其用於治療嚴重潰瘍性大腸炎患者的依曲莫德新藥認證申請。指定發炎性腸道疾病治療方法和核准新藥的有利監管努力正在推動市場擴張。

市場相關人員和非營利組織之間加強合作，應對開發 IBD 治療新療法的各種挑戰，預計將推動市場成長。例如，2022年10月，精準健康公司Verily與克隆氏症和結腸炎基金會擴大了策略夥伴關係，以加速潰瘍性大腸炎和克隆氏症的研究。此外，歐洲克隆氏症和結腸炎組織已採取一些積極措施來改善發炎性腸道疾病疾病患者的照護。

最近核准用於治療發炎性腸道疾病，如 filgotinib、 ozanimod、 Upadacitinib和 risankizumab，預計將在未來幾年支持市場成長。此外，監管機構鼓勵製造商開發針對罕見和危及生命的疾病的新治療方法。例如，2020年12月，Thetis Pharmaceuticals的TP-317獲得美國FDA授予的孤兒藥資格，用於治療小兒潰瘍性大腸炎。這些有利的舉措預計將促進研發活動，開發 IBD 的新型治療產品。

此外，用於治療各種發炎疾病的生物相似藥的需求和核准不斷成長是市場的影響因素。例如，2022年12月，美國FDA核准Idacio作為第八個Adalimumab單抗生物相似藥。新核准的生物相似藥是一種不含檸檬酸鹽的低濃度製劑，旨在治療成人和 6 歲及以上兒童的多種發炎疾病，包括 CD。此外，2021年10月，美國FDA核准Ciltezo用於治療中重度CD和UC。此外，擴大引入生物相似藥預計將推動新興經濟體採用生物製藥來治療 IBD。

此外，政府機構正在努力促進生物相似藥的安全使用。例如，2022 年 10 月，薩斯喀徹爾省政府推出了一項舉措，幫助居民獲得更便宜、更高品質的治療。同樣，安大略省和魁北克省等加拿大省份正在擴大其生物相似舉措，以加速生物相似藥候選藥物的採用。

發炎性腸道疾病市場報告亮點

  • 由於生物製藥作為治療劑的盛行率不斷增加和處方率較高，克隆氏症領域佔據了最大的市場佔有率。
  • 由於用於治療潰瘍性大腸炎的生物製藥的核准不斷增加以及龐大的患者群體，潰瘍性大腸炎市場預計將錄得最快的成長率。
  • 由於 IBD 治療的處方率較高以及消費者對 TNF 抑制劑的認知不斷增強，TNF 抑制劑細分市場在 2023 年佔據最大的市場佔有率。
  • 從給藥途徑來看，注射劑細分市場將在 2023 年主導發炎性腸道疾病治療市場，而口服細分市場預計將成長最快。
  • 2023年，由於住院率上升和有利的報銷選擇，醫院藥房部門成為最大的部門。
  • 由於市場參與企業增加投資以及該地區疾病盛行率上升，預計亞太地區在預測期內將呈現最快的成長速度。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章發炎性腸道疾病治療市場變數、趨勢、範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 發炎性腸道疾病治療市場分析工具
    • 波特的分析
    • PESTEL分析
  • 主要產品一覽表及平均售價

第4章發炎性腸道疾病治療市場：按類型估計和趨勢分析

  • 細分儀表板
  • 發炎性腸道疾病治療市場：2023 年和 2030 年按類型分類的變化分析
  • 克隆氏症
  • 潰瘍性大腸炎

第5章發炎性腸道疾病治療市場：按藥物類別估計和趨勢分析

  • 細分儀表板
  • 發炎性腸道疾病治療市場：2023 年和 2030 年按藥物類別的變化分析
  • 胺基水楊酸
  • 皮質類固醇
  • 腫瘤壞死因子抑制劑
  • IL抑制劑
  • 抗整合素
  • JAK抑制劑
  • 其他

第6章發炎性腸道疾病治療市場：依給藥途徑估計與趨勢分析

  • 細分儀表板
  • 發炎性腸道疾病治療市場：2023 年和 2030 年按給藥途徑的變化分析
  • 口服
  • 注射

第7章發炎性腸道疾病治療市場：按分銷管道估計和趨勢分析

  • 細分儀表板
  • 發炎性腸道疾病治療市場：2023 年和 2030 年按分銷管道分類的變化分析
  • 醫院藥房
  • 零售藥房
  • 網路藥房

第8章發炎性腸道疾病疾病治療市場：區域估計和趨勢分析

  • 2023年及2030年發炎性腸道疾病治療市場佔有率（按地區）
  • 北美洲
    • 2018-2030年北美發炎性腸道疾病治療市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 2018-2030年歐洲發炎性腸道疾病治療市場估計與預測
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年亞太地區發炎性腸道疾病治療市場估計與預測
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 新加坡
    • 泰國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲發炎性腸道疾病治療市場估計與預測
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 2018-2030年中東和非洲發炎性腸道疾病治療市場估計和預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 2023 年企業市場佔有率分析
  • 策略規劃
    • 擴張
    • 併購
    • 夥伴關係與協作
    • 新產品發布
    • 研究與開發
  • 公司簡介
    • AbbVie Inc.
    • Takeda Pharmaceutical Company Limited
    • Pfizer Inc.
    • Biogen
    • Novartis AG
    • Lilly
    • UCB SA
    • CELLTRION INC.
    • Merck &Co., Inc.
    • Johnson &Johnson Services, Inc
Product Code: GVR-3-68038-114-6

Inflammatory Bowel Disease Treatment Market Growth & Trends:

The global inflammatory bowel disease treatment market size is expected to reach USD 27.73 billion by 2030, expanding at a CAGR of 3.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of the disease, the surge in awareness about inflammatory bowel disease among people, and favorable regulatory scenarios are projected to drive the inflammatory bowel disease treatment market over the forecast period. For instance, in December 2022, Pfizer Inc. announced the U.S. FDA acceptance for review of an NDA for etrasimod for patients having severe ulcerative colitis. The favorable initiatives undertaken by regulatory authorities for treatment designations and approval of novel drugs for the management of inflammatory bowel disease are fueling market expansion.

The increasing collaboration of market players and non-profit organizations to counter various challenges in the development of novel therapeutics for IBD treatment is projected to propel market growth. For instance, in October 2022, Verily, a precision health company and the Crohn's & Colitis Foundation expanded their strategic collaboration to accelerate research in ulcerative colitis and Crohn's disease. In addition, the European Crohn's and Colitis Organization has taken several favorable steps to improve the care of patients living with inflammatory bowel disease.

Recently approved novel drugs such as filgotinib, ozanimod, upadacitinib, and risankizumab for the treatment of inflammatory bowel disease are expected to support market growth in the coming years. Moreover, the regulatory authorities are encouraging manufacturers to develop novel therapeutic approaches for rare and life-threatening diseases. For instance, in December 2020, Thetis Pharmaceuticals received an orphan drug designation for TP-317 from the U.S. FDA for pediatric ulcerative colitis. Such favorable initiatives are expected to boost the R&D activities to develop novel therapeutic products for IBD.

Furthermore, the rising demand & approvals for biosimilars for the treatment of various inflammatory conditions is a high-impact rendering factor for the market. For instance, in December 2022, the U.S. FDA approved Idacio as an eighth adalimumab biosimilar in the U.S. The newly approved biosimilar is a citrate-free low-concentration preparation intended for the treatment of several inflammatory conditions, including CD in adults and children aged 6 years or older. In addition, in October 2021, the U.S. FDA approved Cyltezo for the management of moderate to severe CD and UC. Moreover, the increasing introduction of biosimilars is expected to boost the adoption of biological products for the treatment of IBD in developing economies.

Moreover, government bodies are taking efforts to promote the uptake of biosimilars with their safe use. For instance, in October 2022, the government of Saskatchewan launched a biosimilar initiative to help its residents to access high-quality therapeutics at a lesser cost. Similarly, provinces like Ontario and Quebec in Canada are also expanding biosimilar initiatives to promote the uptake of biosimilar candidates.

Inflammatory Bowel Disease Market Report Highlights:

  • The Crohn's disease segment held the largest share owing to the increasing prevalence of the condition and the high prescription rate of biologics for the treatment of the disease
  • The ulcerative colitis segment is poised to register the fastest growth rate due to the rising approval of biologics for the treatment of ulcerative colitis and the high patient base
  • The TNF inhibitors segment accounted for the largest market share in 2023 owing to the high prescription rate for the treatment of IBD and rising consumer awareness about TNF inhibitors
  • Based on the route of administration, the injectable segment dominated the inflammatory bowel disease treatment market in 2023, whereas the oral segment is anticipated to be the fastest-growing segment
  • The hospital pharmacy segment was the largest in 2023, owing to higher hospitalization rates and favorable reimbursement coverage
  • Asia Pacific is expected to exhibit the fastest growth rate over the forecast period due to the rising investments by market players and increasing disease prevalence in the region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type
    • 1.2.2. Drug Class
    • 1.2.3. Route of Administration
    • 1.2.4. Distribution Channel
  • 1.3. Regional Scope
  • 1.4. Estimates and Forecast Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased Database
    • 1.6.2. GVR's Internal Database
  • 1.7. Details of primary research
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity flow analysis (Model 1)
      • 1.9.1.1. Approach 1: Commodity flow approach
    • 1.9.2. Volume price analysis (Model 2)
      • 1.9.2.1. Approach 2: Volume price analysis
  • 1.10. Research Scope and Assumptions
    • 1.10.1. List of Secondary Sources
    • 1.10.2. List of Primary Sources
    • 1.10.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Inflammatory Bowel Disease Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Robust product pipeline
      • 3.2.1.2. High prevalence of Crohn's disease and ulcerative colitis
      • 3.2.1.3. Increasing geriatric population
      • 3.2.1.4. Emergence of biosimilars
      • 3.2.1.5. Support of regulatory bodies for funding and designation
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. High cost of treatment
      • 3.2.2.2. Lack of early diagnosis
  • 3.3. Inflammatory Bowel Disease Treatment Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Legal landscape
  • 3.4. List of Main Products & Average Selling Price

Chapter 4. Inflammatory Bowel Disease Treatment Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Inflammatory Bowel Disease Treatment Market: Type Movement Analysis, USD Billion, 2023 & 2030
  • 4.3. Crohn's Disease
    • 4.3.1. Crohn's Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 4.4. Ulcerative Colitis
    • 4.4.1. Ulcerative Colitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 5. Inflammatory Bowel Disease Treatment Market: Drug Class Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Inflammatory Bowel Disease Treatment Market: Drug Class Movement Analysis, USD Billion, 2023 & 2030
  • 5.3. Aminosalicylates
    • 5.3.1. Aminosalicylates Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.4. Corticosteroids
    • 5.4.1. Corticosteroids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.5. TNF Inhibitors
    • 5.5.1. TNF Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.6. IL Inhibitors
    • 5.6.1. IL Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.7. Anti-integrin
    • 5.7.1. Anti-integrin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.8. JAK Inhibitors
    • 5.8.1. JAK Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 5.9. Others
    • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 6. Inflammatory Bowel Disease Treatment Market: Route of Administration Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Inflammatory Bowel Disease Treatment Market: Route of Administration Movement Analysis, USD Billion, 2023 & 2030
  • 6.3. Oral
    • 6.3.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 6.4. Injectable
    • 6.4.1. Injectable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 7. Inflammatory Bowel Disease Treatment Market: Distribution Channel Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Inflammatory Bowel Disease Treatment Market: Distribution Channel Movement Analysis, USD Billion, 2023 & 2030
  • 7.3. Hospital Pharmacy
    • 7.3.1. Hospital Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.4. Retail Pharmacy
    • 7.4.1. Retail Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 7.5. Online Pharmacy
    • 7.5.1. Online Pharmacy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 8. Inflammatory Bowel Disease Treatment Market: Regional Estimates & Trend Analysis

  • 8.1. Inflammatory Bowel Disease Treatment Market Share, By Region, 2023 & 2030, USD Billion
  • 8.2. North America
    • 8.2.1. North America Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.2.2. U.S.
      • 8.2.2.1. Key Country Dynamics
      • 8.2.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.2.2.3. Competitive Insights
      • 8.2.2.4. U.S. Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.2.3. Canada
      • 8.2.3.1. Key Country Dynamics
      • 8.2.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.2.3.3. Competitive Insights
      • 8.2.3.4. Canada Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.3. Europe
    • 8.3.1. Europe Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.2. Germany
      • 8.3.2.1. Key Country Dynamics
      • 8.3.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.2.3. Competitive Insights
      • 8.3.2.4. Germany Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.3. UK
      • 8.3.3.1. Key Country Dynamics
      • 8.3.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.3.3. Competitive Insights
      • 8.3.3.4. UK Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.4. Spain
      • 8.3.4.1. Key Country Dynamics
      • 8.3.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.4.3. Competitive Insights
      • 8.3.4.4. Spain Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.5. France
      • 8.3.5.1. Key Country Dynamics
      • 8.3.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.5.3. Competitive Insights
      • 8.3.5.4. France Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.6. Italy
      • 8.3.6.1. Key Country Dynamics
      • 8.3.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.6.3. Competitive Insights
      • 8.3.6.4. Italy Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.7. Denmark
      • 8.3.7.1. Key Country Dynamics
      • 8.3.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.7.3. Competitive Insights
      • 8.3.7.4. Denmark Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.8. Sweden
      • 8.3.8.1. Key Country Dynamics
      • 8.3.8.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.8.3. Competitive Insights
      • 8.3.8.4. Sweden Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.3.9. Norway
      • 8.3.9.1. Key Country Dynamics
      • 8.3.9.2. Regulatory Landscape/Reimbursement Scenario
      • 8.3.9.3. Competitive Insights
      • 8.3.9.4. Norway Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.2. Japan
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.4.2.3. Competitive Insights
      • 8.4.2.4. Japan Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.3. China
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.4.3.3. Competitive Insights
      • 8.4.3.4. China Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.4. India
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.4.4.3. Competitive Insights
      • 8.4.4.4. India Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.5. South Korea
      • 8.4.5.1. Key Country Dynamics
      • 8.4.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.4.5.3. Competitive Insights
      • 8.4.5.4. South Korea Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.6. Australia
      • 8.4.6.1. Key Country Dynamics
      • 8.4.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.4.6.3. Competitive Insights
      • 8.4.6.4. Australia Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.7. Singapore
      • 8.4.7.1. Key Country Dynamics
      • 8.4.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.4.7.3. Competitive Insights
      • 8.4.7.4. Singapore Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.4.8. Thailand
      • 8.4.8.1. Key Country Dynamics
      • 8.4.8.2. Regulatory Landscape/Reimbursement Scenario
      • 8.4.8.3. Competitive Insights
      • 8.4.8.4. Thailand Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.5. Latin America
    • 8.5.1. Latin America Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.5.2. Brazil
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.5.2.3. Competitive Insights
      • 8.5.2.4. Brazil Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.5.3. Mexico
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.5.3.3. Competitive Insights
      • 8.5.3.4. Mexico Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.5.4. Argentina
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.5.4.3. Competitive Insights
      • 8.5.4.4. Argentina Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.2. South Africa
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.6.2.3. Competitive Insights
      • 8.6.2.4. South Africa Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.6.3.3. Competitive Insights
      • 8.6.3.4. Saudi Arabia Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.4. UAE
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.6.4.3. Competitive Insights
      • 8.6.4.4. UAE Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
    • 8.6.5. Kuwait
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.6.5.3. Competitive Insights
      • 8.6.5.4. Kuwait Inflammatory Bowel Disease Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Strategy Mapping
    • 9.4.1. Expansion
    • 9.4.2. Mergers & Acquisition
    • 9.4.3. Partnerships & Collaborations
    • 9.4.4. New Product Launches
    • 9.4.5. Research And Development
  • 9.5. Company Profiles
    • 9.5.1. AbbVie Inc.
      • 9.5.1.1. Participant's Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Recent Developments
    • 9.5.2. Takeda Pharmaceutical Company Limited
      • 9.5.2.1. Participant's Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Recent Developments
    • 9.5.3. Pfizer Inc.
      • 9.5.3.1. Participant's Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Recent Developments
    • 9.5.4. Biogen
      • 9.5.4.1. Participant's Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Recent Developments
    • 9.5.5. Novartis AG
      • 9.5.5.1. Participant's Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Recent Developments
    • 9.5.6. Lilly
      • 9.5.6.1. Participant's Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Recent Developments
    • 9.5.7. UCB S.A.
      • 9.5.7.1. Participant's Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Recent Developments
    • 9.5.8. CELLTRION INC.
      • 9.5.8.1. Participant's Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Recent Developments
    • 9.5.9. Merck & Co., Inc.
      • 9.5.9.1. Participant's Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Recent Developments
    • 9.5.10. Johnson & Johnson Services, Inc
      • 9.5.10.1. Participant's Overview
      • 9.5.10.2. Financial Performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Recent Developments

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness Highest Growth
  • Table 4 Global Inflammatory Bowel Disease Treatment Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 6 Global Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 7 Global Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 8 Global Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 9 North America Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 10 North America Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 11 North America Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 12 North America Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 13 North America Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 14 U.S. Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 15 U.S. Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 16 U.S. Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 17 U.S. Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 18 Canada Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 19 Canada Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 20 Canada Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 21 Canada Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 22 Europe Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 23 Europe Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 24 Europe Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 25 Europe Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 26 Europe Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 27 Germany Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 28 Germany Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 29 Germany Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 30 Germany Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 31 UK Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 32 UK Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 33 UK Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 34 UK Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 35 France Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 36 France Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 37 France Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 38 France Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 39 Italy Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 40 Italy Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 41 Italy Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 42 Italy Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 43 Spain Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 44 Spain Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 45 Spain Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 46 Spain Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 47 Denmark Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 48 Denmark Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 49 Denmark Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 50 Denmark Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 51 Sweden Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 52 Sweden Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 53 Sweden Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 54 Sweden Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 55 Norway Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 56 Norway Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 57 Norway Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 58 Norway Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 59 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 60 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 61 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 64 Japan Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 65 Japan Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 66 Japan Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 67 Japan Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 68 China Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 69 China Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 70 China Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 71 China Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 72 India Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 73 India Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 74 India Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 75 India Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 76 South Korea Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 77 South Korea Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 78 South Korea Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 79 South Korea Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 80 Australia Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 81 Australia Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 82 Australia Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 83 Australia Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 84 Singapore Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 85 Singapore Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 86 Singapore Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 87 Singapore Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 88 Thailand Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 89 Thailand Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 90 Thailand Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 91 Thailand Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 92 Latin America Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 93 Latin America Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 94 Latin America Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 95 Latin America Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 96 Latin America Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 97 Mexico Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 98 Mexico Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 99 Mexico Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 100 Mexico Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 101 Brazil Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 102 Brazil Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 103 Brazil Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 104 Brazil Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 105 Argentina Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 106 Argentina Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 107 Argentina Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 108 Argentina Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 109 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
  • Table 110 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 111 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 112 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 113 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 114 South Africa Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 115 South Africa Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 116 South Africa Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 117 South Africa Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 118 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 119 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 120 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 121 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 122 UAE Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 123 UAE Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 124 UAE Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 125 UAE Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
  • Table 126 Kuwait Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
  • Table 127 Kuwait Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
  • Table 128 Kuwait Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
  • Table 129 Kuwait Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Inflammatory bowel disease treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2023)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Inflammatory bowel disease treatment market: Type movement analysis
  • Fig. 17 Inflammatory bowel disease treatment market: Type segment dashboard
  • Fig. 18 Inflammatory bowel disease treatment market Type outlook: Key takeaways
  • Fig. 19 Crohn's disease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Ulcerative Colitis market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Inflammatory bowel disease treatment market: Drug class movement analysis
  • Fig. 22 Inflammatory bowel disease treatment market: Drug class segment dashboard
  • Fig. 23 Inflammatory bowel disease treatment market Drug class outlook: Key takeaways
  • Fig. 24 Aminosalicylates market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 TNF inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 IL inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Anti-integrin market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 JAK inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Inflammatory bowel disease treatment market: Route of administration movement analysis
  • Fig. 32 Inflammatory bowel disease treatment market: Route of administration segment dashboard
  • Fig. 33 Inflammatory bowel disease treatment market Route of administration outlook: Key takeaways
  • Fig. 34 Oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Injectable market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Inflammatory bowel disease treatment market: Distribution channel movement analysis
  • Fig. 37 Inflammatory bowel disease treatment market: Distribution channel segment dashboard
  • Fig. 38 Inflammatory bowel disease treatment market Distribution channel outlook: Key takeaways
  • Fig. 39 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Online pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Regional outlook, 2023 & 2030
  • Fig. 43 Regional market dashboard
  • Fig. 44 Regional market place: Key takeaways
  • Fig. 45 North America, SWOT
  • Fig. 46 Europe, SWOT
  • Fig. 47 Asia Pacific, SWOT
  • Fig. 48 Latin America, SWOT
  • Fig. 49 Middle East and Africa, SWOT
  • Fig. 50 North America
  • Fig. 51 North America inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 52 U.S.
  • Fig. 53 U.S. inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 54 Canada
  • Fig. 55 Canada inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 56 Europe
  • Fig. 57 Europe inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 58 UK
  • Fig. 59 UK inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 60 Germany
  • Fig. 61 Germany inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 62 Spain
  • Fig. 63 Spain inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 64 France
  • Fig. 65 France inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 66 Italy
  • Fig. 67 Italy inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 68 Denmark
  • Fig. 69 Denmark inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 70 Norway
  • Fig. 71 Norway inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 72 Sweden
  • Fig. 73 Sweden inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 74 Asia Pacific
  • Fig. 75 Asia Pacific inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 76 Japan
  • Fig. 77 Japan inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 78 China
  • Fig. 79 China inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 80 India
  • Fig. 81 India inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 82 South Korea
  • Fig. 83 South Korea inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 84 Australia
  • Fig. 85 Australia inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 86 Singapore
  • Fig. 87 Singapore inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 88 Thailand
  • Fig. 89 Thailand inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 90 Latin America
  • Fig. 91 Latin America inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 92 Brazil
  • Fig. 93 Brazil inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 94 Mexico
  • Fig. 95 Mexico inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 96 Argentina
  • Fig. 97 Argentina inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 98 Middle East and Africa
  • Fig. 99 MEA inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 100 South Africa
  • Fig. 101 South Africa inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 102 Saudi Arabia
  • Fig. 103 Saudi Arabia inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 104 UAE
  • Fig. 105 UAE inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 106 Kuwait
  • Fig. 107 Kuwait inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 108 Ansoff Matrix
  • Fig. 109 Heat map analysis
  • Fig. 110 Market differentiators